Calcineurin, Mitochondrial Membrane Potential, and Cardiomyocyte Apoptosis
2001; Lippincott Williams & Wilkins; Volume: 88; Issue: 12 Linguagem: Inglês
10.1161/hh1201.093159
ISSN1524-4571
Autores Tópico(s)Signaling Pathways in Disease
ResumoHomeCirculation ResearchVol. 88, No. 12Calcineurin, Mitochondrial Membrane Potential, and Cardiomyocyte Apoptosis Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBCalcineurin, Mitochondrial Membrane Potential, and Cardiomyocyte Apoptosis Jeffery D. Molkentin Jeffery D. MolkentinJeffery D. Molkentin From the Department of Pediatrics, University of Cincinnati, Children's Hospital Medical Center, Division of Molecular Cardiovascular Biology, Cincinnati, Ohio. Originally published22 Jun 2001https://doi.org/10.1161/hh1201.093159Circulation Research. 2001;88:1220–1222Mitochondria comprise ≈30% of the total intracellular volume within a mammalian cardiomyocyte.12 Not surprisingly, subtle alterations in mitochondrial function or membrane potential can have a dramatic influence on cardiomyocyte energy production and, ultimately, the health of an individual cell. Indeed, cellular injury or stress stimulation directly elicits alterations in mitochondrial architecture, membrane potential, and oxidative capacity, which are associated with an irreversible loss of mitochondrial matrix contents and integral membrane protein constituents such as cytochrome c oxidase.3 The release of cytochrome c and/or mitochondrial permeability transition directly mediates cellular apoptosis through calcium-sensitive proteases or through coupling proteins that coordinate the activation of caspases and DNA fragmentation enzymes.3 Given the high intracellular content of mitochondria in cardiomyocytes and the unabated requirement for high-energy phosphate carriers to maintain ionic gradients and active force generation, coordinated disturbances in mitochondrial function can dramatically affect cell survival.Recent investigation has suggested an emerging paradigm whereby stress-responsive intracellular signaling pathways directly and indirectly influence mitochondrial membrane potential, oxidative capacity, and the coupling of apoptosis initiating factors. For example, stress-responsive signaling through the c-Jun N-terminal kinases (JNKs) has been shown to initiate apoptosis in certain cell types by directly influencing proteins within the mitochondrial membranes.4 In addition, increased expression of the mitochondrial stabilizing Bcl proteins can be transcriptionally regulated through stress-responsive signaling pathways, which subsequently antagonize mitochondrial dysfunction and cytochrome c release.5 Activation of the intracellular kinase Akt also directly antagonizes mitochondrial-directed apoptosis by phosphorylating the mitochondrial destabilizing protein Bad, reducing cytochrome c release and caspase activation.6 Lastly, activation of nuclear factor-κB (NF-κB) signaling induces expression of stress-adaptive proteins such as Bcl-2, antioxidants, and calcium-regulating proteins.7 In general, signaling pathways such as the stress- and mitogen-activated protein kinases (SAPKs and MAPKs), protein kinase C (PKC), Akt, NF-κB, and the calcium-activated phosphatase calcineurin respond to extracellular stress and/or receptor-activated signal transduction as a means of modulating cell survival against diverse cytopathic stimuli. Given the critical role of mitochondria in cellular homeostasis, additional pathways will likely be elucidated whereby stress-responsive signaling pathways adjust mitochondrial characteristics in an attempt to preserve function, or alternatively, to coordinate cellular apoptosis.Adult cardiomyocytes are thought to be largely refractory to cell cycle reentry and cytokinesis.89 Thus, apoptotic events in the myocardium likely result in a cumulative decrease in cell number, which is thought to be a contributing factor in heart failure.10 The description of apoptosis in the failing myocardium was initially controversial, in part, due to unusually high approximations of overall levels. However, more recent calculations in several animal models of cardiomyopathy, as well as failed human hearts, have confirmed the increased occurrence of cardiomyocyte apoptosis as a potential contributing factor in the progressive loss of pump function.10 In contrast to the low but cumulative levels of apoptosis identified in the failing heart, acute myocardial infarction promotes massive apoptosis of cardiomyocytes due to a primary lack of oxygen and/or a reperfusion-induced hyperemia that is associated with free radical production.11 In response to ischemic injury or various forms of cardiomyopathy, many of the stress-responsive signaling pathways discussed above are activated or pathologically regulated.12 Indeed, stress-responsive signaling pathways not only coordinate alterations in cellular physiology and gene expression, but they also contribute to the regulation of cellular apoptosis.One potential regulator of stress responses and apoptosis in cardiomyocytes is the calcium/calmodulin–activated protein phosphatase calcineurin (or PP2B). Calcineurin was initially identified as an important regulator of cardiomyocyte hypertrophy in vivo and in vitro.1314 However, more recent investigation has suggested a role for calcineurin in the regulation of cardiomyocyte apoptosis. Such a concept is not unique to cardiomyocytes, as dozens of studies have previously identified a critical role for calcineurin as an effector of apoptosis in other cell types. Studies conducted in neurons, lymphocytes, and cancer cell lines have demonstrated either pro- or antiapoptotic effects of calcineurin activation.1516171819202122 The exact decision of cytoprotection versus apoptosis is likely regulated by coordinated signals from other costimulated signaling pathways. Indeed, calcineurin activation was recently shown either to induce apoptosis or to antagonize apoptosis depending on the status of p38 MAPK activation.23 However, the role that calcineurin plays in regulating cardiomyocyte apoptosis and the potential modulatory effects of parallel regulatory pathways has not, until recently, been investigated.In this issue of Circulation Research, Kakita et al24 identify an antiapoptotic effect associated with calcineurin activation in cardiomyocytes. Endothelin-1 stimulation of cardiomyocytes was protective against H2O2-induced TUNEL reactivity, DNA laddering, caspase-3 cleavage, and loss of mitochondrial membrane potential.24 Endothelin-1 stimulation also promoted NFAT dephosphorylation, which is a highly specific indicator of calcineurin activation. More importantly, endothelin-1–mediated cytoprotection from H2O2-induced apoptosis was blocked by inhibition of calcineurin with either cyclosporin A or FK506. These results suggest that calcineurin activation normally antagonizes cardiomyocyte apoptosis in response to H2O2 injury. The results of Kakita et al24 are supported and refuted by two recent studies discussed below.De Windt et al14 reported that calcineurin activation protected cardiomyocytes from apoptotic stimulation both in vitro and in vivo, supporting the findings of Kakita et al.24 Cultured neonatal cardiomyocytes infected with an adenovirus encoding an activated form of calcineurin were protected against 2-deoxyglucose–induced apoptosis.14 More importantly, transgenic mice expressing an activated form of calcineurin in the heart were largely protected from ischemia/reperfusion-induced DNA laddering, suggesting that calcineurin activation antagonizes cardiomyocyte apoptosis in vivo.14 In this same report, cyclosporin A also reversed the protective effects of α-adrenergic stimulation in the presence of 2-deoxyglucose treatment in vitro. Collectively, De Windt et al14 and Kakita et al24 provide reasonable support for the hypothesis that calcineurin activation is normally cytoprotective in cardiomyocytes.Molecular mechanisms associated with calcineurin-mediated cardioprotection have also been suggested. Kakita et al24 reported that calcineurin activation promoted an increase in Bcl-2 expression, suggesting a potential mechanism for downregulated apoptosis through enhanced mitochondrial membrane stability. Similarly, De Windt et al14 reported that calcineurin activation was associated with Akt phosphorylation, which also enhances mitochondrial membrane stability through Bad phosphorylation. However, it is uncertain if calcineurin directly regulates the expression of antiapoptotic cellular machinery, or if calcineurin activation simply antagonizes apoptosis as a secondary consequence of initiating the entire hypertrophic program.In contrast, Saito et al25 reported that isoproterenol stimulation of cardiac β-adrenergic receptors promoted myocyte apoptosis, in part, by stimulating calcineurin activity. Saito et al25 demonstrated that cyclosporin A and FK506 blocked the increase in cardiomyocyte apoptosis induced by isoproterenol stimulation and, more significantly, that transgenic mice expressing dominant-negative calcineurin in the heart were refractory to isoproterenol-induced TUNEL reactivity in vivo. These results suggest that calcineurin activation is associated with enhanced apoptosis in cardiomyocytes. However, Saito et al25 also reported that transgenic mice expressing dominant-negative calcineurin in the heart have increased apoptosis in response to ischemia/reperfusion injury, supporting the contrary hypothesis that calcineurin activation is cardioprotective. These seemingly contradictory data underscore the complexity of intracellular signaling networks within mammalian cells, such that related stress stimuli can elicit fundamentally different responses. Indeed, the most probable explanation for such divergent data, which are even manifested within a single report, is that calcineurin signaling is interpreted within a molecular context of other signaling pathways. This interpretation is also supported by the observed dichotomous role of calcineurin in regulating apoptosis of neurons and lymphocytes discussed above.151617181920212223 Given these considerations, calcineurin is likely a more peripheral effector of apoptosis that depends on cellular context and coordinated actions of other signaling pathways.The assertion that calcineurin can have both anti- and proapoptotic regulatory roles should be considered within context of the multiple mechanisms whereby a cell can undergo apoptosis (mitochondrial- versus death receptor–mediated). In addition, the interpretation of the role of calcineurin as an apoptotic regulator can be complicated by known side effects of the often-used calcineurin inhibitor cyclosporin A. Most notably, cyclosporin A inhibits mitochondrial destabilization by directly binding to cyclophilin D, which associates with the adenine nucleotide translocator in the inner mitochondrial membrane to regulate permeability pore transition.26 Indeed, it is not valid to assume that the effects of cyclosporin A on apoptosis are mediated entirely by calcineurin inhibition. For example, cyclosporin A infusion can protect hearts from ischemia/reperfusion-induced injury by preventing mitochondrial permeability transition.27That maintaining mitochondrial stability is critical for protecting cardiomyocytes from apoptotic stimuli, such as ischemia/reperfusion, is also highlighted by another report in this issue of Circulation Research. Akao et al28 demonstrate that maintenance of mitochondrial membrane potential through controlled activation of ATP-sensitive potassium channels prevents oxidative stress–induced cellular apoptosis in cultured cardiomyocytes. Indeed, emerging evidence suggests a paradigm whereby activation of ATP-sensitive potassium channels in the mitochondrial inner membrane can preserve membrane potential and is a significant mechanism of preconditioning-associated cytoprotection.2930 Akao et al28 demonstrated that H2O2-induced loss of mitochondrial membrane potential and ensuing apoptosis were antagonized with the ATP-sensitive potassium channel–gating agent diazoxide. Diazoxide-mediated preservation of mitochondrial membrane potential was recently associated with a reversal in mitochondrial matrix contraction and a maintenance in mitochondrial intermembrane volumes, suggesting a structural mechanism underlying the observed protection.31 Collectively, these results underscore the importance of preserving mitochondrial function and architecture during noxious stimuli as a means of inhibiting cardiomyocyte apoptosis.In summary, the literature supports a convergence of dissimilar mechanisms to collectively target the mitochondria in an attempt to fine-tune cellular viability in response to pleiotropic insults or agonist stimulation. Indeed, direct effectors of mitochondrial integrity, such as diazoxide and cyclosporin A, can function as potent suppressors of membrane destabilization and the subsequent initiation of apoptosis (although by different mechanisms). Furthermore, an emerging body of literature suggests that intracellular signaling pathways directly and indirectly regulate mitochondrial membrane stability and the apoptotic fate of a cell. Given the central position that mitochondria occupy in cardiomyocytes, future investigations into the mechanisms whereby signaling pathways affect mitochondrial stability will be particularly relevant. Indeed, a better understanding of the molecular effectors that modulate mitochondrial integrity will likely suggest new strategies for protecting cardiomyocytes from ischemic insults.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.FootnotesCorrespondence to Jeffery D. Molkentin, PhD, Children's Hospital Medical Center, Division of Molecular Cardiovascular Biology, 3333 Burnet Ave, Cincinnati, OH 45229-3039. E-mail [email protected] References 1 Kim HD, Kim CH, Rah BJ, Chung HI, Shim TS. Quantitative study on the relation between structural and functional properties of the hearts from three different mammals. Anat Rec.1994; 238:199–206.CrossrefMedlineGoogle Scholar2 Barth E, Stammler G, Speiser B, Schaper J. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol.1992; 24:669–681.CrossrefMedlineGoogle Scholar3 Hengartner MO. The biochemistry of apoptosis. Nature.2000; 407:770–776.CrossrefMedlineGoogle Scholar4 Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c–mediated death pathway. Science.2000; 288:870–874.CrossrefMedlineGoogle Scholar5 Grad JM, Zeng XR, Boise LH. Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol.2000; 12:543–549.CrossrefMedlineGoogle Scholar6 Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev.1999; 13:2905–2927.CrossrefMedlineGoogle Scholar7 Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res.2000; 301:173–187.CrossrefMedlineGoogle Scholar8 Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res.1998; 83:1–14.CrossrefMedlineGoogle Scholar9 Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res.1998; 83:15–26.CrossrefMedlineGoogle Scholar10 Kang PM, Izumo S. Apoptosis and heart failure: a critical review of the literature. Circ Res.2000; 86:1107–1113.CrossrefMedlineGoogle Scholar11 Elsasser A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol.2000; 32:711–724.CrossrefMedlineGoogle Scholar12 Molkentin JD, Dorn GW II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol.2001; 63:391–426.CrossrefMedlineGoogle Scholar13 Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell.1998; 93:215–228.CrossrefMedlineGoogle Scholar14 De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW II, Kitsis RN, Molkentin JD. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res.2000; 86:255–263.CrossrefMedlineGoogle Scholar15 Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science.1999; 284:339–343.CrossrefMedlineGoogle Scholar16 Tombal B, Weeraratna AT, Denmeade SR, Isaacs JT. Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells. Prostate.2000; 43:303–317.CrossrefMedlineGoogle Scholar17 Jayaraman T, Marks AR. Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways. J Biol Chem.2000; 275:6417–6420.CrossrefMedlineGoogle Scholar18 Shibasaki F, McKeon F. Calcineurin functions in Ca2+-activated cell death in mammalian cells. J Cell Biol.1995; 131:735–743.CrossrefMedlineGoogle Scholar19 Zhao Y, Tozawa Y, Iseki R, Mukai M, Iwata M. Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. J Immunol.1995; 154:6346–6354.MedlineGoogle Scholar20 Asada A, Zhao Y, Kondo S, Iwata M. Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem.1998; 273:28392–28398.CrossrefMedlineGoogle Scholar21 Ankarcrona M, Dypbukt JM, Orrenius S, Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett.1996; 394:321–324.CrossrefMedlineGoogle Scholar22 Wood AM, Bristow DR. N-methyl-d-aspartate receptor desensitisation is neuroprotective by inhibiting glutamate-induced apoptotic-like death. J Neurochem.1998; 70:677–687.MedlineGoogle Scholar23 Lotem J, Kama R, Sachs L. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. Proc Natl Acad Sci U S A.1999; 96:12016–12020.CrossrefMedlineGoogle Scholar24 Kakita T, Hasegawa K, Iwai-Kanai E, Adachi S, Morimoto T, Wada H, Kawamura T, Yanazume T, Sasayama S. Calcineurin pathway is required for endothelin-1–mediated protection against oxidant stress–induced apoptosis in cardiac myocytes. Circ Res.2001; 88:1239–1246.CrossrefMedlineGoogle Scholar25 Saito S, Hiroi Y, Zou Y, Aikawa R, Toko H, Shibasaki F, Yazaki Y, Nagai R, Komuro I. β-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J Biol Chem.2000; 275:34528–34533.CrossrefMedlineGoogle Scholar26 Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol.2000; 529:11–21.CrossrefMedlineGoogle Scholar27 Halestrap AP, Connern CP, Griffiths EJ, Kerr PM. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem.1997; 174:167–172.CrossrefMedlineGoogle Scholar28 Akao M, Ohler A, O'Rourke B, Marbán E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis by oxidative stress in cardiac cells. Circ Res.2001; 88:1267–1275.CrossrefMedlineGoogle Scholar29 O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res.2000; 87:845–855.CrossrefMedlineGoogle Scholar30 Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, Marbán E, Mitochondrial ATP-dependent potassium channels: viable candidate effectors of ischemic preconditioning. Ann N Y Acad Sci.1999; 874:27–37.CrossrefMedlineGoogle Scholar31 Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria. Am J Physiol Heart Circ Physiol.2001; 280:H649–H657.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Kim S, Lahu G, Vakilynejad M, Soldatos T, Jackson D, Lesko L and Trame M (2022) A case study of a patient‐centered reverse translational systems‐based approach to understand adverse event profiles in drug development, Clinical and Translational Science, 10.1111/cts.13219, 15:4, (1003-1013), Online publication date: 1-Apr-2022. Liu X, Gao S, Gao H, Jiang X and Wei Q (2021) Mitochondrial disruption is involved in the effect of NFATc4 on aggravating cardiomyocyte hypertrophy, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000986, Publish Ahead of Print, Online publication date: 16-Feb-2021. Xiao L, Xu J, Weng Q, Zhou L, Wang M, Liu M and Li Q Mechanism of a Novel Camptothecin-Deoxycholic Acid Derivate Induced Apoptosis against Human Liver Cancer HepG2 Cells and Human Colon Cancer HCT116 Cells, Recent Patents on Anti-Cancer Drug Discovery, 10.2174/1574892814666191016162346, 14:4, (370-382) Sharma R and Parameswaran S (2018) Calmodulin-binding proteins: A journey of 40 years, Cell Calcium, 10.1016/j.ceca.2018.09.002, 75, (89-100), Online publication date: 1-Nov-2018. Fadda L, Attia H, Al-Rasheed N, Ali H and Al-Rasheed N (2018) Roles of some antioxidants in modulation of cardiac myopathy induced by sodium nitrite via down-regulation of mRNA expression of NF-κB, Bax, and flt-1 and suppressing DNA damage, Saudi Pharmaceutical Journal, 10.1016/j.jsps.2017.12.008, 26:2, (217-223), Online publication date: 1-Feb-2018. Shah S, Hussain T, Zhao D and Yang L (2016) A central role for calcineurin in protein misfolding neurodegenerative diseases, Cellular and Molecular Life Sciences, 10.1007/s00018-016-2379-7, 74:6, (1061-1074), Online publication date: 1-Mar-2017. Tajeddine N (2016) How do reactive oxygen species and calcium trigger mitochondrial membrane permeabilisation?, Biochimica et Biophysica Acta (BBA) - General Subjects, 10.1016/j.bbagen.2016.02.013, 1860:6, (1079-1088), Online publication date: 1-Jun-2016. Nanayakkara G, Alasmari A, Mouli S, Eldoumani H, Quindry J, McGinnis G, Fu X, Berlin A, Peters B, Zhong J and Amin R (2015) Cardioprotective HIF-1α-frataxin signaling against ischemia-reperfusion injury, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00875.2014, 309:5, (H867-H879), Online publication date: 1-Sep-2015. Al-Rasheed N, Faddah L, Ibrahim H, Mohamed A, Al-Rasheed N and Abdelbaky N (2015) Role of Carnosine and Melatonin in Ameliorating Cardiotoxicity of Titanium Dioxide Nanoparticles in the Rats, Brazilian Archives of Biology and Technology, 10.1590/S1516-8913201500014, 58:4, (577-586), Online publication date: 1-Aug-2015. Toledo F, Pérez L, Basiglio C, Ochoa J, Sanchez Pozzi E and Roma M (2014) The Ca2+-calmodulin-Ca2+/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes, Archives of Toxicology, 10.1007/s00204-014-1219-5, 88:9, (1695-1709), Online publication date: 1-Sep-2014. Gao S, Li H, Cai Y, Ye J, Liu Z, Lu J, Huang X, Feng X, Gao H, Chen S, Li M and Liu P (2014) Mitochondrial binding of α-enolase stabilizes mitochondrial membrane: Its role in doxorubicin-induced cardiomyocyte apoptosis, Archives of Biochemistry and Biophysics, 10.1016/j.abb.2013.12.008, 542, (46-55), Online publication date: 1-Jan-2014. Ye Q, Feng Y, Yin Y, Faucher F, Currie M, Rahman M, Jin J, Li S, Wei Q and Jia Z (2013) Structural basis of calcineurin activation by calmodulin, Cellular Signalling, 10.1016/j.cellsig.2013.08.033, 25:12, (2661-2667), Online publication date: 1-Dec-2013. Guo J, Mi S, Li J, Liu W, Yin Y and Wei Q (2012) Calcineurin B subunit acts as a potential agent for preventing cardiac ischemia/reperfusion injury, Molecular and Cellular Biochemistry, 10.1007/s11010-012-1407-7, 370:1-2, (163-171), Online publication date: 1-Nov-2012. Kurji K and Sharma R (2009) Potential role of calcineurin in pathogenic conditions, Molecular and Cellular Biochemistry, 10.1007/s11010-009-0346-4, 338:1-2, (133-141), Online publication date: 1-May-2010. Garciarena C, Caldiz C, Portiansky E, Chiappe de Cingolani G and Ennis I (2009) Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart, Journal of Applied Physiology, 10.1152/japplphysiol.91300.2008, 106:4, (1325-1331), Online publication date: 1-Apr-2009. Kato M, Akao M, Matsumoto-Ida M, Makiyama T, Iguchi M, Takeda T, Shimizu S and Kita T (2009) The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging, Cardiovascular Research, 10.1093/cvr/cvp094, 83:2, (335-344), Online publication date: 15-Jul-2009., Online publication date: 15-Jul-2009. Kuo W, Chung L, Liu C, Wu S, Kuo C, Tsai F, Tsai C, Lu M, Huang C and Lee S (2009) Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats, Cell Biochemistry and Function, 10.1002/cbf.1601, 27:7, (479-487), Online publication date: 1-Oct-2009. Somers J, Beck P, Lees-Miller J, Roach D, Li Y, Guo J, Loken S, Zhan S, Semeniuk L and Duff H (2008) iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00386.2008, 295:3, (H1122-H1131), Online publication date: 1-Sep-2008. Stupka N, Schertzer J, Bassel-Duby R, Olson E and Lynch G (2007) Calcineurin-Aα activation enhances the structure and function of regenerating muscles after myotoxic injury, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00612.2006, 293:2, (R686-R694), Online publication date: 1-Aug-2007. Champattanachai V, Marchase R and Chatham J (2007) Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O -GlcNAc , American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00162.2006, 292:1, (C178-C187), Online publication date: 1-Jan-2007. Paul M, Patkari M and Mukhopadhayay A (2007) Existence of a distinct concentration window governing daunorubicin-induced mammalian liver mitotoxicity—implication for determining therapeutic window, Biochemical Pharmacology, 10.1016/j.bcp.2007.06.009, 74:6, (821-830), Online publication date: 1-Sep-2007. Xie J and Yu L (2007) Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion, Acta Anaesthesiologica Scandinavica, 10.1111/j.1399-6576.2007.01342.x, 51:7, (909-913), Online publication date: 1-Aug-2007. Gupta M, Neelakantan T, Sanghamitra M, Tyagi R, Dinda A, Maulik S, Mukhopadhyay C and Goswami S (2006) An Assessment of the Role of Reactive Oxygen Species and Redox Signaling in Norepinephrine-Induced Apoptosis and Hypertrophy of H9c2 Cardiac Myoblasts, Antioxidants & Redox Signaling, 10.1089/ars.2006.8.1081, 8:5-6, (1081-1093), Online publication date: 1-May-2006. Tamareille S, Mignen O, Capiod T, Rücker-Martin C and Feuvray D (2006) High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells, Cell Calcium, 10.1016/j.ceca.2005.09.008, 39:1, (47-55), Online publication date: 1-Jan-2006. Zhou B, Wu L, Li L, Tashiro S, Onodera S, Uchiumi F and Ikejima T (2006) Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1, Journal of Pharmacological Sciences, 10.1254/jphs.FPJ06005X, 102:4, (387-395), . Martínez-Martínez S, Rodríguez A, López-Maderuelo M, Ortega-Pérez I, Vázquez J and Redondo J (2006) Blockade of NFAT Activation by the Second Calcineurin Binding Site, Journal of Biological Chemistry, 10.1074/jbc.M513885200, 281:10, (6227-6235), Online publication date: 1-Mar-2006. Zocchi M, Contini P, Alfano M and Poggi A (2005) Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-β Production by NK Cells and TGF-β-Mediated NK Cell Apoptosis, The Journal of Immunology, 10.4049/jimmunol.174.10.6054, 174:10, (6054-6061), Online publication date: 15-May-2005. Lakshmikuttyamma A, Selvakumar P, Sharma A and Sharma R (2011) Involvement of calcineurin in ischemic myocardial damage, International Journal of Angiology, 10.1007/s00547-005-2005-2, 14:01, (1-6) Schomisch S, Murdock D, Hedayati N, Carino J, Lesnefsky E and Cmolik B (2005) Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: A DNA microarray study, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2005.06.027, 130:4, (1151.e1-1151.e13), Online publication date: 1-Oct-2005. Nathan M, Friehs I, Choi Y, Cowan D, Cao-Danh H, McGowan F and del Nido P (2005) Cyclosporin A But Not FK-506 Protects Against Dopamine-Induced Apoptosis in the Stunned Heart, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2004.10.030, 79:5, (1620-1626), Online publication date: 1-May-2005. Reeve J, Duffy A, O'Brien T and Samali A (2005) Don't lose heart - therapeutic value of apoptosis prevention in the treatment of cardiovascular disease, Journal of Cellular and Molecular Medicine, 10.1111/j.1582-4934.2005.tb00492.x, 9:3, (609-622), Online publication date: 1-Jul-2005. Selvakumar P, Lakshmikuttyamma A, Anderson D and Sharma R (2005) Molecular cloning, expression, purification and characterization of calcineurin from bovine cardiac muscle, Biochimie, 10.1016/j.biochi.2005.04.010, 87:11, (975-983), Online publication date: 1-Nov-2005. Eigel B, Gursahani H and Hadley R (2004) Na + /Ca 2+ exchanger plays a key role in inducing apoptosis after hypoxia in cultured guinea pig ventricular myocytes , American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00874.2003, 287:4, (H1466-H1475), Online publication date: 1-Oct-2004. Sun H, Wang N, Halkos M, Kerendi F, Kin H, Wang R, Guyton R and Zhao Z (2004) Involvement of Na+/H+ exchanger in hypoxia/re-oxygenation-induced neonatal rat cardiomyocyte apoptosis, European Journal of Pharmacology, 10.1016/j.ejphar.2003.12.016, 486:2, (121-131), Online publication date: 1-Feb-2004. Wilkins B and Molkentin J (2004) Calcium–calcineurin signaling in the regulation of cardiac hypertrophy, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2004.07.121, 322:4, (1178-1191), Online publication date: 1-Oct-2004. Lakshmikuttyamma A, Selvakumar P, Kakkar R, Kanthan R, Wang R and Sharma R (2003) Activation of calcineurin expression in ischemia-reperfused rat heart and in human ischemic myocardium, Journal of Cellular Biochemistry, 10.1002/jcb.10722, 90:5, (987-997), Online publication date: 1-Dec-2003. Iwai-Kanai E, Hasegawa K, Adachi S, Fujita M, Akao M, Kawamura T and Kita T (2003) Effects of endothelin-1 on mitochondrial function during the protection against myocardial cell apoptosis, Biochemical and Biophysical Research Communications, 10.1016/S0006-291X(03)00839-8, 305:4, (898-903), Online publication date: 1-Jun-2003. Bueno O, van Rooij E, Molkentin J, Doevendans P and De Windt L (2002) Calcineurin and hypertrophic heart disease: novel insights and remaining questions, Cardiovascular Research, 10.1016/S0008-6363(01)00493-X, 53:4, (806-821), Online publication date: 1-Mar-2002., Online publication date: 1-Mar-2002. Pang Y, Hunton D, Bounelis P and Marchase R (2002) Hyperglycemia Inhibits Capacitative Calcium Entry and Hypertrophy in Neonatal Cardiomyocytes, Diabetes, 10.2337/diabetes.51.12.3461, 51:12, (3461-3467), Online publication date: 1-Dec-2002. Wilkins B and Molkentin J (2002) Calcineurin and cardiac hypertrophy: Where have we been? Where are we going?, The Journal of Physiology, 10.1113/jphysiol.2002.017129, 541:1, (1-8), Online publication date: 1-May-2002. Weng X, Zhang X, Lu X, Wu J and Li S (2018) Reduced mitochondrial response sensitivity is involved in the anti‑apoptotic effect of dexmedetomidine pretreatment in cardiomyocytes, International Journal of Molecular Medicine, 10.3892/ijmm.2018.3384 Tsai C, Kuo W, Shibu M, Lin Y, Liu C, Chen Y, Day C, Shen C, Viswanadha V, Huang C and Mohanraj R (2017) E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling, PLOS ONE, 10.1371/journal.pone.0184153, 12:9, (e0184153) June 22, 2001Vol 88, Issue 12 Advertisement Article InformationMetrics © 2001 American Heart Association, Inc.https://doi.org/10.1161/hh1201.093159 Originally publishedJune 22, 2001 KeywordsheartischemiamitochondriaapoptosiscalcineurinPDF download Advertisement
Referência(s)